Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 20C (PRR20C) is a predicted human protein encoded by the PRR20C gene, one of a cluster of five nearly identical loci located on chromosome 13q21.1[2]. The protein is characterized by a high content of the amino acid proline, a feature that is often associated with protein-protein interaction motifs and may influence protein folding and structure[1][4]. Members of the proline-rich protein 20 family, including PRR20A, PRR20B, PRR20C, PRR20D, and PRR20E, are classified based on their sequence but lack experimental evidence for specific biological or disease-related functions[2]. No direct evidence links PRR20C or its family members to classic therapeutic target classes (such as receptor, enzyme, transporter, ion channel, or transcription factor)[2]. Consequently, there are no drugs, biomarkers, disease roles, or mechanisms of action documented for this protein. PRR20C remains a poorly characterized protein and is currently not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 20C (PRR20C).